Talaromyces (Penicillium) marneffei infection | Zendy

Qian Du | Zendy; Chak Kwan Tong | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Talaromyces (Penicillium) marneffei infection

Author(s) -

Qian Du,

Chak Kwan Tong

Publication year - 2018

Publication title -

idcases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.319

H-Index - 13

ISSN - 2214-2509

DOI - 10.1016/j.idcr.2018.e00428

Subject(s) - penicillium marneffei , medicine , itraconazole , amphotericin b , sputum , sore throat , human immunodeficiency virus (hiv) , dermatology , microbiology and biotechnology , virology , immunology , pathology , antifungal , tuberculosis , coinfection , biology

A 41-year-old man from the emergency department presented with fever for 2 weeks, sore throat, dry cough and generalized umbilicated skin lesions (face (Fig. 1), and chest (Fig. 2)). HIV antibody was positive, CD4+ count was 2/μL. His skin swab, sputum and blood culture all yielded Talaromyces (Penicillium) marneffei (Fig. 3). Talaromyces marneffei is an important cause of morbidity and mortality in HIV-infected and other immunosuppressed patients who live in or are from endemic areas especially Southeast Asia. Amphotericin B or Itraconazole should be initiated as soon as possible for patients with talaromycosis.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research